Latest Kelso Technologies I (KEOSF) Headlines
Kelso Technologies Inc.: New Patent-Dual Rating Pressure Relief Valve
Marketwire - Thu Feb 20, 8:04AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has filed a patent application for a new externally mounted dual rating pressure relief valve ("DPRV") design for use on new rail tank cars and retrofits of existing rail tank cars.
Kelso Ranked as 2014 TSX Venture 50(R) Company
Marketwire - Wed Feb 12, 11:08AM CST
Kelso Technologies Inc. (the "Company" or "Kelso") (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Advanced Proteome Therapeutics Corp. (APC) Provides Update on Ongoing Activities
Marketwire - Thu Dec 19, 1:07PM CST
Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) is pleased to announce that through calendar year 2013 the Company has been applying its enabling Foundation Trinity(TM) Technology to proteins targeted for the treatment of cancers. Advanced, targeted therapies are intended to attack primarily cancer cells and are expected to dominate the anti-cancer therapeutics market in the near future. APC's technology will enable not only therapy targeted for tumor cells, but also the delivery of combination therapy in a single, pure therapeutic agent. To achieve this, it has been the Company's intention to utilize a unique protein, not only as a delivery system to tumor cells, but also as a scaffold upon which to attach each anti-cancer entity to its own specific site on the protein surface - both key to efficient manufacturing and product development. What is more, the protein itself appears to possess immunotherapeutic properties. Immunotherapy is perhaps the most powerful current approach to cancer, and one of great commercial interest to the pharmaceutical industry. This vision, the unique nature of the protein, and the ability to apply its proprietary enabling chemical technology to modification of the protein, differentiate APC from the competition.
C5 Insight Lauded With Top Awards and Honors in 2013
GlobeNewswire - Wed Dec 18, 2:09PM CST
C5 Insight, a technology consulting firm that specializes in customizing and implementing multiple customer relationship management (CRM) and enterprise collaboration solutions, reports another year of award-winning growth and success.
Kelso Clears SEC Review of Form 20-F Registration Statement
Marketwire - Wed Dec 18, 8:04AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) (the "Company" or "Kelso") -
Kelso Files Form 20-F/A Amendment No. 3 to Registration Statement with SEC
Marketwire - Wed Dec 04, 8:03AM CST
Kelso Technologies Inc. (the "Company" or "Kelso") (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Bonham Production Facility
Marketwire - Wed Nov 27, 8:01AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) (the "Company" or "Kelso") -
Kelso Technologies Inc.: Advantages of Manway Confirmed in Bakken Oil Fields
Marketwire - Tue Nov 19, 8:03AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) (the "Company" or "Kelso") -
Kelso Technologies Inc.: Financial Results for the Nine Months Ended September 30, 2013
Marketwire - Wed Nov 13, 8:03AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) (The "Company" or "Kelso") -
Kelso Technologies Inc.: AAR Clears KKM for Full Commercial Use
Marketwire - Tue Oct 29, 8:04AM CDT
Kelso Technologies Inc. (the "Company" or "Kelso") (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Kelso Technologies Inc.: New Patent-Dual Rating Pressure Relief Valve
Marketwire - Thu Feb 20, 8:04AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has filed a patent application for a new externally mounted dual rating pressure relief valve ("DPRV") design for use on new rail tank cars and retrofits of existing rail tank cars.
Kelso Ranked as 2014 TSX Venture 50(R) Company
Marketwire - Wed Feb 12, 11:08AM CST
Kelso Technologies Inc. (the "Company" or "Kelso") (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Advanced Proteome Therapeutics Corp. (APC) Provides Update on Ongoing Activities
Marketwire - Thu Dec 19, 1:07PM CST
Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) is pleased to announce that through calendar year 2013 the Company has been applying its enabling Foundation Trinity(TM) Technology to proteins targeted for the treatment of cancers. Advanced, targeted therapies are intended to attack primarily cancer cells and are expected to dominate the anti-cancer therapeutics market in the near future. APC's technology will enable not only therapy targeted for tumor cells, but also the delivery of combination therapy in a single, pure therapeutic agent. To achieve this, it has been the Company's intention to utilize a unique protein, not only as a delivery system to tumor cells, but also as a scaffold upon which to attach each anti-cancer entity to its own specific site on the protein surface - both key to efficient manufacturing and product development. What is more, the protein itself appears to possess immunotherapeutic properties. Immunotherapy is perhaps the most powerful current approach to cancer, and one of great commercial interest to the pharmaceutical industry. This vision, the unique nature of the protein, and the ability to apply its proprietary enabling chemical technology to modification of the protein, differentiate APC from the competition.
C5 Insight Lauded With Top Awards and Honors in 2013
GlobeNewswire - Wed Dec 18, 2:09PM CST
C5 Insight, a technology consulting firm that specializes in customizing and implementing multiple customer relationship management (CRM) and enterprise collaboration solutions, reports another year of award-winning growth and success.
Kelso Clears SEC Review of Form 20-F Registration Statement
Marketwire - Wed Dec 18, 8:04AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) (the "Company" or "Kelso") -
Kelso Files Form 20-F/A Amendment No. 3 to Registration Statement with SEC
Marketwire - Wed Dec 04, 8:03AM CST
Kelso Technologies Inc. (the "Company" or "Kelso") (TSX VENTURE: KLS)(OTCQX: KEOSF) -
Bonham Production Facility
Marketwire - Wed Nov 27, 8:01AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) (the "Company" or "Kelso") -
Kelso Technologies Inc.: Advantages of Manway Confirmed in Bakken Oil Fields
Marketwire - Tue Nov 19, 8:03AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) (the "Company" or "Kelso") -
Kelso Technologies Inc.: Financial Results for the Nine Months Ended September 30, 2013
Marketwire - Wed Nov 13, 8:03AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) (The "Company" or "Kelso") -
Kelso Technologies Inc.: AAR Clears KKM for Full Commercial Use
Marketwire - Tue Oct 29, 8:04AM CDT
Kelso Technologies Inc. (the "Company" or "Kelso") (TSX VENTURE: KLS)(OTCQX: KEOSF) -
